Advertisement
Screener

XENETIC BIOSCIENCES, INC. (XBIO) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

XENETIC BIOSCIENCES, INC. Cash Flow Breakdown

Cash flow breakdown shows where XENETIC BIOSCIENCES, INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $2.29M went out.
  • Fiscal year ended 2025-12-31: from financing, $4.00M came in.
  • Fiscal year ended 2025-12-31: change in cash, $1.72M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingDebt paid backNew debtNew shares soldNot split outChange in cash
2025-12-31-$2.29M$4.00M$1.72M
2024-12-31-$2.82M$0.00-$2.82M
2023-12-31-$4.11M$0.00-$4.11M
2022-12-31-$4.65M-$500.00K$0.00-$5.15M
2021-12-31-$4.74M$0.00$11.45M$6.72M
2020-12-31-$4.27M$0.00$5.43M$1.16M
2019-12-31-$6.40M$2.00K$0.00$16.13M*$9.73M
2018-12-31-$6.46M$22.50K$1.48M*-$4.96M
2017-12-31$1.49M-$9.26K$0.00$0.00$1.48M
2016-12-31-$8.79M-$16.79K-$369.96K$4.50M$8.59M*
2015-12-31-$5.30M$6.22K-$100.00K$3.10M$0.00
2014-12-31-$12.68M-$52.18K$0.00$0.00$10.00M
2013-12-31-$6.05M-$144.63K$2.09K
2013-08-31$280.61K-$259.39K
2012-12-31-$6.26M-$92.59K$421.16K*
2012-08-31-$12.99K$35.00K

Each quarter (3 month)

Quarter endRunning the businessFrom investingDebt paid backNew debtNew shares soldNot split outChange in cash
2026-06-30-$875.49K*
2026-03-31-$536.38K-$536.38K
2025-12-31-$242.68K*
2025-09-30-$658.25K*
2025-06-30-$383.83K*
2025-03-31-$1.00M-$1.00M
2024-12-31-$673.99K*
2024-09-30-$459.04K*
2024-06-30-$525.10K*
2024-03-31-$1.16M-$1.16M
2023-12-31-$793.03K*$0.00*
2023-09-30-$949.63K*$0.00*
2023-06-30-$1.27M*
2023-03-31-$1.10M-$1.10M
2022-12-31-$750.91K*$0.00*$0.00*
2022-09-30-$1.08M*$0.00*
2022-06-30-$728.90K*
2022-03-31-$2.09M-$2.09M
2021-12-31-$1.46M*$0.00*$0.00*
2021-09-30-$1.03M*$0.00*
2021-06-30-$726.81K*
2021-03-31-$1.52M-$1.52M
2020-12-31-$953.66K*$0.00*$5.43M*
2020-09-30-$1.01M*$0.00*
2020-06-30-$1.30M*$0.00*
2020-03-31-$1.00M$0.00-$1.00M
2019-12-31-$1.68M*$0.00*
2019-09-30-$2.42M*$0.00*$13.43M*
2019-06-30-$1.05M*$0.00*
2019-03-31-$1.25M$2.00K$2.70M*$1.45M
2018-12-31-$1.04M*$0.00*
2018-09-30-$1.67M*$22.50K*
2018-06-30-$2.09M*$0.00*$1.48M*
2018-03-31-$1.67M$0.00-$1.67M
2017-12-31$4.84M*$0.00*$0.00*
2017-09-30-$1.64M*$0.00*$0.00*
2017-06-30-$1.99M*-$3.83K*$0.00*
2017-03-31$280.81K-$5.43K$0.00$275.38K
2016-12-31-$4.62M*-$2.18K*$0.00*$8.46M*
2016-09-30-$1.03M*$0.00*$1.00M*
2016-06-30-$1.36M*$0.00*$0.00*
2016-03-31-$1.77M-$14.61K$3.50M
2015-12-31-$1.12M*$1.64K*$0.00*$0.00*$0.00*
2015-09-30-$1.96M*-$1.00*$3.00M*$0.00*
2015-06-30-$193.56K*-$1.66K*$100.00K*$0.00*
2015-03-31-$2.04M$6.25K$0.00$0.00
2014-12-31-$2.66M*-$11.66K*$0.00*$0.00*$0.00*
2014-09-30-$2.68M*-$6.42K*$0.00*
2014-06-30-$3.21M*-$22.61K*$0.00*
2014-03-31-$4.12M-$11.49K$10.00M
2013-12-31-$2.01M*-$129.83K*
2013-11-30-$173.14K
2013-09-30-$2.26M*-$4.97K*
2013-08-31$250.43K*
2013-06-30-$839.82K*-$5.74K*
2013-05-31$17.21K*
2013-03-31-$942.28K-$4.09K
2012-08-31-$1.05K*$0.00*
2012-05-31-$13.30K*
2012-02-29$3.18K*
2011-11-30-$1.82K

Similar stocks

Stock NameCountryMarket CapPE Ratio
ProPhase Labs, Inc. (PRPH)United States$0.006B-0.06
Processa Pharmaceuticals, Inc. (PCSA)United States$0.005B
AMARIN CORP PLC\UK (AMRN)$0.005B-247.24
Pulmatrix, Inc. (PULM)United States$0.006B
Ernexa Therapeutics Inc. (ERNA)United States$0.006B
Dermata Therapeutics, Inc. (DRMA)United States$0.005B-0.62
REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)United States$0.005B
Cadrenal Therapeutics, Inc. (CVKD)United States$0.004B-0.90
Lakewood-Amedex Biotherapeutics Inc. (LABT)United States$0.004B
Enveric Biosciences, Inc. (ENVB)United States$0.007B-0.63